Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2004-03-04
2009-06-09
Lukton, David (Department: 1654)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C424S400000, C436S529000, C514S059000, C524S054000
Reexamination Certificate
active
07544656
ABSTRACT:
A method of lowering blood glucose in a mammal includes injecting a therapeutically effective amount of crystallized dextran microparticles and insulin to the mammal to lower blood glucose of the mammal. The composition may be a one phase or a structured multi-phase composition for controlled release of insulin over an extended period of time.
REFERENCES:
patent: 4713249 (1987-12-01), Schroder
patent: 4963526 (1990-10-01), Ecanow
patent: 6264943 (2001-07-01), Cherksey
patent: 6303148 (2001-10-01), Hennink et al.
patent: 6395302 (2002-05-01), Hennink et al.
patent: 6482413 (2002-11-01), Chalasani et al.
patent: RE37950 (2002-12-01), Dunn et al.
patent: 2002/0054914 (2002-05-01), Morcol et al.
patent: 2004/0048782 (2004-03-01), Bryson
patent: 1 371 364 (2003-12-01), None
patent: WO 87/02704 (1987-05-01), None
patent: WO 99/02107 (1999-01-01), None
patent: WO 02/28374 (2002-04-01), None
patent: WO 02/39985 (2002-05-01), None
US 5,849,884, 12/1998, Woiszwillo et al. (withdrawn)
Eliaz R., Szoka F., Gene Therapy 9 (2002): 1230-1237.
Blain J.F., Maghni K., Pelletier S. and Sirois P. Inflamm. Res. 48 (1999): 386-392.
Crystallized carbohydrate spheres as a slow release matrix for biologically active substances, Ulf Schroder, Biomaterials 1984, vol. 5 March.
Crytallized Carbohydrate Spheres for Slow Release and Targeting, Ulf Schroder, Methods in Enzymology, vol. 12.
Surfactant-Free Preparation of Biodegradable Hydrogel Microspheres for Protein Release, Yasuhiko Tabata, et al., Journal of Bioactive and Compatible Polymers, vol. 14-Sep. 1999.
Partitioning in Aqueous Two-Phase Systems. A comprehensive bioliography in three parts: (1956-1984; 1985-1990; 1991-present) Part III: 1991-present Part II: 1985-1990.
Local and distant transfection of mdx muscle fibers with dystrophin and LacZ genes delivered in vivo by synthetic microspheres, A. Baranov, et al., Gene Therapy 6 (1999), 1406-1414.
Regulated insulin release from biodegradable dextran hydrogels containing poly(ethylene glycol), Kazuteru Moriyama, et al., Journal of Controlled Release 42 (1996) 237-248.
Lantus Prescribing Information—Aventis Pharmaceuticals (http://www.aventis-us.com/PIs/Iantus—TXT.html visited Feb. 23, 2004.
Sephadex-based cell-affinity adsorbents: preparation and performance, Geert Besselink, et al, Biotechnol., Appl. Biochem. 35 (2002), 55-60.
Formation of dextran hydrogels by crystallization, R.J.H. Stenekes, et al., Biomaterials 22 (2001) 1891-0898.
Enhanced Loading and Activity Retention of Proteins in Hydrogel Delivery Systems, S.H. Gehrke, et al, Proceed. Intern. Symp. Control. Rel. Bioact. Mater., 22 (1995), Controlled Release Society, Inc., p. 145-146.
Amidon GL, Lee HJ, Absorption of Peptide and Peptidomimetic Drugs, Ann. Rev. Pharamcol. Toxicol 1994; 34:321-41.
Abstract, Pharamcological Management of Type 2 Diabetes Mellitus: rationale for rational use of insulin., Mayo Clin Proc. Apr. 2003; 78(4): 459-67, Chan JL, Abrahamson MJ, May Clin Proc. Apr. 2003;78(4):411-3.
Soon-Shiong, “Encapsulated islet cell therapy for the treatment of diabetes: Intraperitoneal injection of islets,”Journal of Controlled Release, May 1, 1996, pp. 399-407, vol. 39, No. 2, Elsevier Science Publishers B.V., Amsterdam, NL.
Crytallized Carbohydrate Spheres for Slow Release and Targeting, Ulf Schroder, Methods in Enzymology, vol. 112, pp. 116-128 (1985).
Alston & Bird LLP
Lukton David
The Technology Development Company, Ltd.
LandOfFree
Long acting injectable insulin composition and methods of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Long acting injectable insulin composition and methods of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Long acting injectable insulin composition and methods of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4146603